Primary Dyslipidemias

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 176 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course Pharmacology of Antihyperlipidemic Medications for Laboratory Professionals. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Pharmacology of Antihyperlipidemic Medications for Laboratory Professionals (online CE course)
Primary Dyslipidemias

Two genetic disorders resulting in elevated cholesterol levels will be discussed.
Familial hypercholesterolemia is a very common genetic disorder, with around 1 in 250 individuals in the United States having a form of the disease. Familial hypercholesterolemia results in extremely high LDL levels. These patients are more likely to have early-onset atherosclerosis. In certain forms of the disease, patients can manifest atherosclerotic disease in childhood and die before age 20.
The pathogenesis of this disease is that there are genetic defects in the gene for the LDL receptors. LDL receptors normally reside on the outside of cells and their function is to remove LDL from the plasma and take it into the cell. In patients with defective LDL receptors, the cholesterol remains in the plasma. These patients require aggressive lipid-lowering therapy. Cholesterol screening begins at two years of age in patients who have first-degree relatives with familial hypercholesterolemia.
Familial hypertriglyceridemia is a genetic disorder in which triglyceride levels are found to be 200-500 mg/dL. Patients with this condition may also have increased LDL cholesterol and have low HDL cholesterol. Pancreatitis is a concern in patients with familial hypertriglyceridemia.